131 related articles for article (PubMed ID: 19198276)
1. [Prostate-specific antigen and telomerase in prostatic cancers].
Poliakovskiĭ KA; Glukhov AI; zezerov EG; Varshavskiĭ VA; Vinarov AZ; Amosov AV; Rapoport LM; Aliaev IuG; Severin ES; Zimnik OV
Klin Lab Diagn; 2008 Dec; (12):37-8. PubMed ID: 19198276
[TBL] [Abstract][Full Text] [Related]
2. Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
Glybochko PV; Zezerov EG; Glukhov AI; Alyaev YG; Severin SE; Polyakovsky KA; Varshavsky VA; Severin ES; Vinarov AZ
Prostate; 2014 Jul; 74(10):1043-51. PubMed ID: 24854433
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Zhang W; Kapusta LR; Slingerland JM; Klotz LH
Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
[TBL] [Abstract][Full Text] [Related]
4. [Detection of telomerase activity in prostate needle-biopsy samples].
Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
[TBL] [Abstract][Full Text] [Related]
5. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
6. [Occurrence of prostatic intraepithelial neoplasia in needle biopsy of the prostate and its clinical significance].
Eliás B; Kliment J; Svihra J; Kalis A
Rozhl Chir; 1997 Sep; 76(9):438-42. PubMed ID: 9471772
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
[TBL] [Abstract][Full Text] [Related]
9. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in needle biopsies from prostate cancer and benign prostates.
Wymenga LF; Wisman GB; Veenstra R; Ruiters MH; Mensink HJ
Eur J Clin Invest; 2000 Apr; 30(4):330-5. PubMed ID: 10759882
[TBL] [Abstract][Full Text] [Related]
11. Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.
Loeb S; Roehl KA; Yu X; Han M; Catalona WJ
Urology; 2007 Jan; 69(1):108-12. PubMed ID: 17270629
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in touch-imprint cell preparations from fresh prostate needle biopsy specimens.
Chieco P; Bertaccini A; Giovannini C; Stecca BA; Martorana G
Eur Urol; 2001 Dec; 40(6):666-72. PubMed ID: 11805415
[TBL] [Abstract][Full Text] [Related]
13. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?
Raviv G; Zlotta AR; Janssen Th; Descamps F; Vanegas JP; Verhest A; Schulman CC
Cancer; 1996 May; 77(10):2103-8. PubMed ID: 8640677
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
Pacelli A; Bostwick DG
Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
[TBL] [Abstract][Full Text] [Related]
15. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
16. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.
Cote RJ; Skinner EC; Salem CE; Mertes SJ; Stanczyk FZ; Henderson BE; Pike MC; Ross RK
Br J Cancer; 1998 Aug; 78(3):413-8. PubMed ID: 9703292
[TBL] [Abstract][Full Text] [Related]
17. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
18. Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score.
De Luca S; Passera R; Milillo A; Coda R; Randone DF
BJU Int; 2012 Dec; 110(11 Pt B):E778-82. PubMed ID: 23116408
[TBL] [Abstract][Full Text] [Related]
19. [Intraepithelial prostatic neoplasia].
Stepanov VN; Frank GA; Dzhioev RR
Urol Nefrol (Mosk); 1999; (1):16-9. PubMed ID: 11149338
[TBL] [Abstract][Full Text] [Related]
20. Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?
Ronnett BM; Carmichael MJ; Carter HB; Epstein JI
J Urol; 1993 Aug; 150(2 Pt 1):386-9. PubMed ID: 7686984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]